제도동향
맞춤의학 : FDA’s Unique Role and Responsibilities in Personalized Medicine
- 등록일2014-02-25
- 조회수6132
- 분류제도동향 > 종합 > 종합
-
자료발간일
2013-10-25
-
출처
FDA
- 원문링크
-
키워드
#Personalized Medicine#맞춤의학
- 첨부파일
Personalized Medicine : FDA’s Unique Role and Responsibilities in Personalized Medicine
The term "personalized medicine" is often described as providing "the right patient with the right drug at the right dose at the right time." More broadly, "personalized medicine" may be thought of as the tailoring of medical treatment to the individual characteristics, needs, and preferences of a patient during all stages of care, including prevention, diagnosis, treatment, and follow-up.
Consistent with FDA's core mission, the agency is working in collaboration with researchers, manufacturers of drugs, medical devices and biologics, health care professionals and others to better understand and adapt to the promise of personalized medicine. FDA's ongoing efforts to make personalized medicine possible touch on various facets of product development and use including:
....(계속)
☞ 자세한 내용은 첨부파일을 참고하시기 바랍니다.
관련정보
지식
동향
- 기술동향 초희귀질환의 유전체 연구를 통한 정밀, 맞춤의학 2016-04-26
- 기술동향 유전체학의 발전과 정밀 맞춤 의학 시대의 도래 2016-01-04
- 기술동향 암 유전체 정보 기반 맞춤의학 2014-08-07
- 정책동향 Personalised Medicine for the European Citizen – Towards more precise medicine for the diagnosis, treatment and prevention of disease (iPM) 2013-01-14
- 특허동향 Mayo v. Prometheus: Implications for Patents, Biotechnology, and Personalized Medicine 2012-11-28